HOME ·

Clinical Trial

HENLIUS(02696.HK): First Patient Dosed in Phase I Clinical Trial of HLX05-N, a Cetuximab Biosimilar, for Metastatic Colorectal Cancer
Tags：
HENLIUS02696.HKClinical Trial
2026-07-08
INSILICO(03696.HK): Phase III Clinical Trial of Rentosertib for Idiopathic Pulmonary Fibrosis Officially Launched
Tags：
Insilico03696.HKClinical Trial
2026-07-08
Mabwell-B(02493.HK): IND Application of 9MW5211 Injection for Type 1 Diabetes Mellitus Accepted by NMPA
Tags：
MABWELL-B02493.HKClinical Trial
2026-07-07
CSPC PHARMA(01093.HK): Phase II Clinical Trial of SYH2070 Injection for Mixed Hyperlipidaemia Initiated at First Clinical Site in China
Tags：
CSPC PHARMA01093.HKClinical Trial
2026-07-07
HENLIUS(02696.HK): Bispecific EGFR/c-MET ADC HLX48 Doses First Patient
Tags：
HENLIUS02696.HKClinical Trial
2026-06-30
REGENT PACIFIC(00575.HK): Deep Longevity Blood Biological Age Model Proven to Predict Mortality and Hospitalisation Risks in Research
Tags：
REGENT PACIFIC00575.HKClinical Trial
2026-06-30
SINO BIOPHARM(01177.HK): Class 1 Innovative Drug Pelecanam Spray (Puyike®) Approved by NMPA for Secondary Wound Infection Caused by Burns and Scalds
Tags：
SINO BIOPHARM01177.HKClinical Trial
2026-06-23
SIHUAN PHARM(00460.HK): First Patient Dosed in Phase III Trial of Anaprazole Sodium from Xuanzhu Biologics for Helicobacter Pylori Eradication
Tags：
SIHUAN PHARM00460.HKClinical Trial
2026-06-22
INNOGEN-B(02591.HK): Ib-stage Clinical Trial of Efsubaglutide Alfa for Adolescent Obesity Approved, Expected to Kick Off in July
Tags：
INNOGEN-B02591.HKClinical Trial
2026-06-22
Henlius(02696.HK):Phase 2 Clinical Trial of HLX43 Combined with Serplulimab for Neoadjuvant Treatment of NSCLC Approved in Australia
Tags：
HENLIUS02696.HKHLX43Clinical Trial
2026-06-16
HENLIUS(02696.HK): HLX04-O Meets Primary Endpoint in Global Multicenter Phase 3 Trial for Wet Age-Related Macular Degeneration
Tags：
HENLIUS02696.HKClinical Trial
2026-06-16
LongBio Pharma-B(01779.HK): LP-003 Phase III Trial for Seasonal Allergic Rhinitis Hits Primary Endpoint
Tags：
LongBio Pharma-B01779.HKClinical Trial
2026-06-12
UNITED LAB(03933.HK): TUL321 Capsule Granted Implied Approval for Clinical Trials of New Drug in China
Tags：
UNITED LAB03933.HKClinical Trial
2026-06-11
CSPC PHARMA(01093.HK): Phase III Study of Anistolimab Combined with HB1801 for HER2-positive Advanced Breast Cancer Meets Primary Endpoint
Tags：
CSPC PHARMA01093.HKClinical Trial
2026-06-10
HBM HOLDINGS-B (02142.HK): NMPA Accepts IND Application of HBM7004 for Advanced Solid Tumors
Tags：
HBM HOLDINGS-B02142.HKClinical Trial
2026-06-10
Leads Biolabs-B (09887.HK): Core Bispecific Antibody Initiates Phase Ib/II Trial for Triple-Negative Breast Cancer
Tags：
LEADS BIOLABS-B09887.HKClinical Trial
2026-02-10